Cargando…
Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide. The ST6 β-galactoside α-2, 6-sialyltransferase 1 (ST6GAL1) has been found aberrantly expressed in a variety of cancers including HCC, but its function and mechanism in regulating liver inflammation remain to be...
Autores principales: | Liu, Ruijia, Cao, Xu, Liang, Yijun, Li, Xiaobin, Jin, Qian, Li, Ying, Du, Hongbo, Zao, Xiaobin, Ye, Yong’an |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553312/ https://www.ncbi.nlm.nih.gov/pubmed/36238765 http://dx.doi.org/10.2147/JIR.S385491 |
Ejemplares similares
-
Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma
por: Li, Shuo, et al.
Publicado: (2023) -
Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy
por: Cao, Xu, et al.
Publicado: (2022) -
Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma
por: Cao, Xu, et al.
Publicado: (2022) -
The host immune response of a discharged COVID-19 patient with twice reemergence of SARS-CoV-2: a case report
por: Zao, Xiaobin, et al.
Publicado: (2021) -
Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis
por: Yao, Yuhao, et al.
Publicado: (2022)